Arkolith/Insider Trading/ZVRA/Form 4

Bode John B

DirectorZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Mar 26, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2026Option exercise(M)39K$4.97$195K84K
Mar 24, 2026Option exercise(M)39K$4.89$192K123K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 24, 2026Option exercise(M)39K—$00
Mar 24, 2026Option exercise(M)39K—$020K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001612084-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML